Cargando…
Therapeutic effects of calcium dobesilate on diabetic nephropathy mediated through reduction of expression of PAI-1
The aim of this study was to investigate whether calcium dobesilate (calcium dihydroxy-2,5-benzenesulfonate) may be used to treat diabetic nephropathy. A total of 121 patients with type 2 diabetic nephropathy received calcium dobesilate (500 mg, 3 times a day) for 3 months. The levels of glycated he...
Autor principal: | ZHANG, XIAOQIAN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524077/ https://www.ncbi.nlm.nih.gov/pubmed/23251286 http://dx.doi.org/10.3892/etm.2012.755 |
Ejemplares similares
-
Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate
por: Qin, Lili, et al.
Publicado: (2017) -
Effect of Calcium Dobesilate in Preventing Contrast-Induced Nephropathy in Patients with Diabetes and Chronic Kidney Disease
por: Zhang, Hao, et al.
Publicado: (2021) -
Mechanisms of retinal neuroprotection of calcium dobesilate: therapeutic implications
por: Simó-Servat, Olga, et al.
Publicado: (2017) -
Calcium dobesilate may alleviate diabetes-induced endothelial dysfunction and inflammation
por: Zhou, Yijun, et al.
Publicado: (2017) -
Molecular Mechanisms and Treatment Strategies in Diabetic Nephropathy: New Avenues for Calcium Dobesilate—Free Radical Scavenger and Growth Factor Inhibition
por: Haller, Hermann, et al.
Publicado: (2017)